CSO, CFO changes at Third Harmonic
Plus: MediLink hires Steve Chin as CMO, and updates from ImmPACT, CTTI, and the Christopher & Dana Reeve Foundation
CSO Adrian Ray will transition to the role of scientific adviser at Third Harmonic Bio Inc. (NASDAQ:THRD) on Nov. 1. In his new role, Ray will continue to support the IND application for THB335, which will be filed in 1H24. Additionally, CFO Robert Ho will depart on Nov. 10. The inflammatory disease company has begun a search for both positions. Last year, the company lost over $600 million in value when it discontinued a Phase Ib trial of THB001 to treat chronic inducible urticaria after elevated liver enzymes were observed in two subjects.
Cancer play MediLink Therapeutics (Suzhou) Co. Ltd. hired Steve Chin as CMO. Chin was most recently CMO at Elpiscience Biopharma Ltd., and before that he served as senior medical director of immuno-oncology, global clinical development at AstraZeneca plc (LSE:AZN; NASDAQ:AZN). ...